Investor
Xontogeny
A life sciences accelerator supporting early-stage biotech, diagnostics, and device companies through seed and series financings.
Stage
Seed–Series B
Sectors
2 sectors
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
About
Xontogeny is a life sciences accelerator that collaborates with entrepreneurs to drive the development of technologies for patients with serious disease. The firm provides seed investment capital across technologies including therapeutics, diagnostics, and devices. These investments include active operational support from team members and strategic consultants. Through a partnership with Perceptive Advisors, the firm also provides series A and B financings to companies across various therapeutic areas.
How to approach
Contact the firm directly to discuss investment strategy and explore collaboration opportunities.
Portfolio · 5 · tap a company to read about it
Recent deals
- 2025-09Crystalys Therapeutics Inc.Series A
- 2025-09Mercy BioAnalytics, Inc.Series B
- 2025-04Merida BiosciencesSeries A
- 2024-06Marea TherapeuticsSeries A
- 2024-04AdaptilensSeries A
- 2024-04NeurosterixSeries A
- 2023-07A-Alpha BioSeries A
- 2023-04TORL BioTherapeuticsSeries B
- 2023-03CARGO TherapeuticsSeries A
- 2022-12Tellus TherapeuticsSeries A
- 2022-12PeroxitechSeries A
- 2022-04Surf BioSeed
- 2022-03VivoSenseSeries ALed
- 2022-01Avenge BioSeries A
- 2021-11Sermonix PharmaceuticalsSeries A